INCYTE CORPORATION Increase (Decrease) in Accrued Liabilities
INCYTE CORPORATION (INCY) reported Increase (Decrease) in Accrued Liabilities of -$84.72 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-04-28
- INCYTE CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$84.72M, a 213.21% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $138.54M, a 6.76% increase year-over-year.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $115.14M, a 5.43% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was -$476.73M.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for fiscal 2025 was -$148.20M, a 153.13% decline from fiscal 2024.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for fiscal 2024 was $278.94M, a 20.95% increase from fiscal 2023.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for fiscal 2023 was $230.61M, a 4.73% increase from fiscal 2022.
- INCYTE CORPORATION increase (decrease) in accrued liabilities for fiscal 2022 was $220.20M, a 67.53% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$84.72M 10-Q · filed 2026-04-28 | $53.82M derived: sum of 2 quarters · filed 2026-04-28 | $168.96M derived: sum of 3 quarters · filed 2026-04-28 | -$307.77M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2025-12-31 | $138.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $253.68M derived: sum of 2 quarters · filed 2026-02-10 | -$223.04M derived: sum of 3 quarters · filed 2026-02-10 | -$148.20M 10-K · filed 2026-02-10 | |
| 2025-09-30 | $115.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$361.59M derived: sum of 2 quarters · filed 2025-10-28 | -$286.75M 10-Q · filed 2025-10-28 | -$156.98M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2025-06-30 | -$476.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$401.88M 10-Q · filed 2025-07-29 | -$272.11M derived: sum of 3 quarters · filed 2026-04-28 | -$150.37M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2025-03-31 | $74.84M 10-Q · filed 2026-04-28 | $204.61M derived: sum of 2 quarters · filed 2026-04-28 | $326.35M derived: sum of 3 quarters · filed 2026-04-28 | $248.32M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $129.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $251.51M derived: sum of 2 quarters · filed 2026-02-10 | $173.47M derived: sum of 3 quarters · filed 2026-02-10 | $278.94M 10-K · filed 2026-02-10 | |
| 2024-09-30 | $121.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $43.70M derived: sum of 2 quarters · filed 2025-10-28 | $149.17M 10-Q · filed 2025-10-28 | $265.39M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-06-30 | -$78.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $27.43M 10-Q · filed 2025-07-29 | $143.65M derived: sum of 3 quarters · filed 2026-02-10 | $165.54M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-03-31 | $105.47M 10-Q · filed 2025-04-29 | $221.69M derived: sum of 2 quarters · filed 2026-02-10 | $243.58M derived: sum of 3 quarters · filed 2026-02-10 | $264.18M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2023-12-31 | $116.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $138.11M derived: sum of 2 quarters · filed 2026-02-10 | $158.71M derived: sum of 3 quarters · filed 2026-02-10 | $230.61M 10-K · filed 2026-02-10 | |
| 2023-09-30 | $21.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $42.49M derived: sum of 2 quarters · filed 2024-10-29 | $114.39M 10-Q · filed 2024-10-29 | $162.20M derived: sum of 4 quarters · filed 2025-02-10 | |
| 2023-06-30 | $20.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $92.50M 10-Q · filed 2024-07-30 | $140.31M derived: sum of 3 quarters · filed 2025-02-10 | $261.05M derived: sum of 4 quarters · filed 2025-02-10 | |
| 2023-03-31 | $71.90M 10-Q · filed 2024-04-30 | $119.71M derived: sum of 2 quarters · filed 2025-02-10 | $240.44M derived: sum of 3 quarters · filed 2025-02-10 | $238.31M derived: sum of 4 quarters · filed 2025-02-10 | |
| 2022-12-31 | $47.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $168.54M derived: sum of 2 quarters · filed 2025-02-10 | $166.41M derived: sum of 3 quarters · filed 2025-02-10 | $220.20M 10-K · filed 2025-02-10 | |
| 2022-09-30 | $120.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $118.60M derived: sum of 2 quarters · filed 2023-10-31 | $172.38M 10-Q · filed 2023-10-31 | $218.79M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $51.65M 10-Q · filed 2023-08-01 | $98.05M derived: sum of 3 quarters · filed 2024-02-13 | $189.47M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-03-31 | $53.79M 10-Q · filed 2023-05-02 | $100.19M derived: sum of 2 quarters · filed 2024-02-13 | $191.61M derived: sum of 3 quarters · filed 2024-02-13 | $187.53M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2021-12-31 | $46.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $137.82M derived: sum of 2 quarters · filed 2024-02-13 | $133.75M derived: sum of 3 quarters · filed 2024-02-13 | $131.44M 10-K · filed 2024-02-13 | |
| 2021-09-30 | $91.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $87.34M derived: sum of 2 quarters · filed 2022-11-01 | $85.04M 10-Q · filed 2022-11-01 | $136.68M derived: sum of 4 quarters · filed 2023-02-07 | |
| 2021-06-30 | -$4.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$6.38M 10-Q · filed 2022-08-02 | $45.26M derived: sum of 3 quarters · filed 2023-02-07 | $69.26M derived: sum of 4 quarters · filed 2023-02-07 | |
| 2021-03-31 | -$2.31M 10-Q · filed 2022-05-03 | -$2.24M 10-Q · filed 2021-05-04 | $49.34M derived: sum of 2 quarters · filed 2023-02-07 | $73.33M derived: sum of 3 quarters · filed 2023-02-07 | $96.99M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $51.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $75.64M derived: sum of 2 quarters · filed 2023-02-07 | $99.30M derived: sum of 3 quarters · filed 2023-02-07 | $113.84M 10-K · filed 2023-02-07 | |
| 2020-09-30 | $23.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $47.65M derived: sum of 2 quarters · filed 2021-11-02 | $62.20M 10-Q · filed 2021-11-02 | $92.19M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-06-30 | $23.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $38.20M 10-Q · filed 2021-08-03 | $68.19M derived: sum of 3 quarters · filed 2022-02-08 | $100.67M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-03-31 | $14.55M 10-Q · filed 2021-05-04 | $44.53M derived: sum of 2 quarters · filed 2022-02-08 | $77.01M derived: sum of 3 quarters · filed 2022-02-08 | $115.52M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2019-12-31 | $29.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $62.47M derived: sum of 2 quarters · filed 2022-02-08 | $100.97M derived: sum of 3 quarters · filed 2022-02-08 | $79.04M 10-K · filed 2022-02-08 | |
| 2019-09-30 | $32.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $70.98M derived: sum of 2 quarters · filed 2020-11-05 | $49.05M 10-Q · filed 2020-11-05 | $45.59M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-06-30 | $38.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $16.58M 10-Q · filed 2020-08-04 | $13.11M derived: sum of 3 quarters · filed 2021-02-09 | $24.61M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-03-31 | -$21.93M 10-Q · filed 2020-05-05 | -$25.40M derived: sum of 2 quarters · filed 2021-02-09 | -$13.90M derived: sum of 3 quarters · filed 2021-02-09 | -$26.68M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2018-12-31 | -$3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $8.03M derived: sum of 2 quarters · filed 2021-02-09 | -$4.75M derived: sum of 3 quarters · filed 2021-02-09 | -$12.03M 10-K · filed 2021-02-09 | |
| 2018-09-30 | $11.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$1.29M derived: sum of 2 quarters · filed 2019-10-29 | -$8.56M 10-Q · filed 2019-10-29 | $42.97M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-06-30 | -$12.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$20.05M 10-Q · filed 2019-07-30 | $31.48M derived: sum of 3 quarters · filed 2020-02-13 | $55.27M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-03-31 | -$7.27M 10-Q · filed 2019-04-30 | $44.26M derived: sum of 2 quarters · filed 2020-02-13 | $68.05M derived: sum of 3 quarters · filed 2020-02-13 | $70.26M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2017-12-31 | $51.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $75.32M derived: sum of 2 quarters · filed 2020-02-13 | $77.53M derived: sum of 3 quarters · filed 2020-02-13 | $87.76M 10-K · filed 2020-02-13 | |
| 2017-09-30 | $23.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $26.00M derived: sum of 2 quarters · filed 2018-10-30 | $36.22M 10-Q · filed 2018-10-30 | $47.68M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $12.44M 10-Q · filed 2018-07-31 | $23.89M derived: sum of 3 quarters · filed 2019-02-14 | $48.44M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-03-31 | $10.23M 10-Q · filed 2018-05-01 | $21.68M derived: sum of 2 quarters · filed 2019-02-14 | $46.23M derived: sum of 3 quarters · filed 2019-02-14 | $7.02M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2016-12-31 | $11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $36.00M derived: sum of 2 quarters · filed 2019-02-14 | -$3.20M derived: sum of 3 quarters · filed 2019-02-14 | $26.48M 10-K · filed 2019-02-14 | |
| 2016-09-30 | $24.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$14.66M derived: sum of 2 quarters · filed 2017-10-31 | $15.02M 10-Q · filed 2017-10-31 | $23.79M derived: sum of 4 quarters · filed 2018-02-15 | |
| 2016-06-30 | -$39.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$9.53M 10-Q · filed 2017-08-01 | -$752.00K derived: sum of 3 quarters · filed 2018-02-15 | $7.85M derived: sum of 4 quarters · filed 2018-02-15 | |
| 2016-03-31 | $29.68M 10-Q · filed 2017-05-04 | $38.45M derived: sum of 2 quarters · filed 2018-02-15 | $47.06M derived: sum of 3 quarters · filed 2018-02-15 | $53.73M derived: sum of 4 quarters · filed 2018-02-15 | |
| 2015-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $17.38M derived: sum of 2 quarters · filed 2018-02-15 | $24.05M derived: sum of 3 quarters · filed 2018-02-15 | $25.25M 10-K · filed 2018-02-15 | |
| 2015-09-30 | $8.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $15.28M derived: sum of 2 quarters · filed 2016-11-01 | $16.47M 10-Q · filed 2016-11-01 | $45.90M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-30 | $6.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $7.87M 10-Q · filed 2016-08-09 | $37.29M derived: sum of 3 quarters · filed 2017-02-14 | $48.13M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-31 | $1.19M 10-Q · filed 2016-05-09 | $30.62M derived: sum of 2 quarters · filed 2017-02-14 | $41.46M derived: sum of 3 quarters · filed 2017-02-14 | $38.93M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-31 | $29.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $40.27M derived: sum of 2 quarters · filed 2017-02-14 | $37.74M derived: sum of 3 quarters · filed 2017-02-14 | $35.53M 10-K · filed 2017-02-14 | |
| 2014-09-30 | $10.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $8.31M derived: sum of 2 quarters · filed 2015-11-03 | $6.10M 10-Q · filed 2015-11-03 | $20.22M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$4.74M 10-Q · filed 2015-08-04 | $9.38M derived: sum of 3 quarters · filed 2016-02-12 | $26.23M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-03-31 | -$2.21M 10-Q · filed 2015-04-30 | $11.91M derived: sum of 2 quarters · filed 2016-02-12 | $28.76M derived: sum of 3 quarters · filed 2016-02-12 | $27.80M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2013-12-31 | $14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $30.96M derived: sum of 2 quarters · filed 2016-02-12 | $30.01M derived: sum of 3 quarters · filed 2016-02-12 | $27.19M 10-K · filed 2016-02-12 | |
| 2013-09-30 | $16.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $15.89M derived: sum of 2 quarters · filed 2014-10-30 | $13.07M 10-Q · filed 2014-10-30 | $20.96M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-30 | -$955.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$3.77M 10-Q · filed 2014-07-31 | $4.11M derived: sum of 3 quarters · filed 2015-02-17 | $9.24M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-31 | -$2.82M 10-Q · filed 2014-05-01 | $5.07M derived: sum of 2 quarters · filed 2015-02-17 | $10.20M derived: sum of 3 quarters · filed 2015-02-17 | $6.62M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2012-12-31 | $7.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $13.02M derived: sum of 2 quarters · filed 2015-02-17 | $9.44M derived: sum of 3 quarters · filed 2015-02-17 | $4.67M 10-K · filed 2015-02-17 | |
| 2012-09-30 | $5.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.56M derived: sum of 2 quarters · filed 2013-10-31 | -$3.22M 10-Q · filed 2013-10-31 | $5.31M derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-06-30 | -$3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$8.35M 10-Q · filed 2013-08-01 | $184.00K derived: sum of 3 quarters · filed 2014-02-21 | $8.23M derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-03-31 | -$4.78M 10-Q · filed 2013-05-02 | $3.76M derived: sum of 2 quarters · filed 2014-02-21 | $11.80M derived: sum of 3 quarters · filed 2014-02-21 | $11.16M derived: sum of 4 quarters · filed 2014-02-21 | |
| 2011-12-31 | $8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $16.58M derived: sum of 2 quarters · filed 2014-02-21 | $15.94M derived: sum of 3 quarters · filed 2014-02-21 | $15.63M 10-K · filed 2014-02-21 | |
| 2011-09-30 | $8.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $7.40M derived: sum of 2 quarters · filed 2012-11-01 | $7.10M 10-Q · filed 2012-11-01 | $114.00K derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-06-30 | -$639.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$944.00K 10-Q · filed 2012-08-03 | -$7.93M derived: sum of 3 quarters · filed 2013-02-21 | $217.00K derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-03-31 | -$305.00K 10-Q · filed 2012-04-26 | -$7.29M derived: sum of 2 quarters · filed 2013-02-21 | $856.00K derived: sum of 3 quarters · filed 2013-02-21 | -$2.39M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2010-12-31 | -$6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $1.16M derived: sum of 2 quarters · filed 2013-02-21 | -$2.09M derived: sum of 3 quarters · filed 2013-02-21 | -$9.27M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $8.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $4.90M derived: sum of 2 quarters · filed 2011-10-27 | -$2.28M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | -$3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$10.43M 10-Q · filed 2011-07-28 | |||
| 2010-03-31 | -$7.18M 10-Q · filed 2011-05-03 | ||||
| 2009-12-31 | $2.42M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |